G1 Therapeutics, Inc. (GTHX)
Sep 18, 2024 - GTHX was delisted (acquired by Pharmacosmos)
7.15
0.00 (0.00%)
Inactive · Last trade price
on Sep 17, 2024
G1 Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -44.77 | -47.97 | -147.56 | -148.35 | -99.25 | -122.45 | Upgrade
|
| Depreciation & Amortization | 0.49 | 0.51 | 0.53 | 0.47 | 0.58 | 0.36 | Upgrade
|
| Other Amortization | 1.25 | 1.47 | 2.23 | 1.11 | 0.62 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.32 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.41 | -2.27 | -0.45 | - | - | - | Upgrade
|
| Stock-Based Compensation | 11.5 | 14.51 | 20.59 | 22.32 | 18.77 | 16.45 | Upgrade
|
| Other Operating Activities | 1.38 | 0.61 | 1.35 | 1.18 | -0.7 | - | Upgrade
|
| Change in Accounts Receivable | -0.14 | -1.59 | -5.41 | -5.45 | -0.24 | - | Upgrade
|
| Change in Inventory | 2.22 | 3.74 | -12.71 | -3.47 | - | - | Upgrade
|
| Change in Accounts Payable | -0.22 | -3.37 | 4.42 | -0.68 | -0.24 | 0.25 | Upgrade
|
| Change in Unearned Revenue | 0.31 | 0.11 | -0.02 | 0.79 | 0.24 | - | Upgrade
|
| Change in Other Net Operating Assets | -7.15 | -4.09 | 8.41 | -0.04 | -3.83 | 5.82 | Upgrade
|
| Operating Cash Flow | -37.54 | -38.34 | -128.62 | -132.11 | -83.74 | -99.57 | Upgrade
|
| Capital Expenditures | - | - | -0.51 | - | - | -2.72 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | - | - | 0.15 | - | Upgrade
|
| Investment in Securities | 5.07 | 2.81 | -50.02 | - | - | - | Upgrade
|
| Investing Cash Flow | 5.07 | 2.81 | -50.53 | - | 0.15 | -2.72 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 55 | 20 | - | Upgrade
|
| Long-Term Debt Repaid | - | -26.69 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -8.75 | -26.69 | - | 55 | 20 | - | Upgrade
|
| Issuance of Common Stock | 0.31 | 0.06 | 52.54 | 92.27 | 2.31 | 2.71 | Upgrade
|
| Other Financing Activities | - | -0.28 | -0.04 | -1.41 | -0.62 | - | Upgrade
|
| Financing Cash Flow | -8.43 | -26.91 | 52.5 | 145.86 | 21.69 | 2.71 | Upgrade
|
| Net Cash Flow | -40.9 | -62.44 | -126.65 | 13.76 | -61.9 | -99.58 | Upgrade
|
| Free Cash Flow | -37.54 | -38.34 | -129.13 | -132.11 | -83.74 | -102.29 | Upgrade
|
| Free Cash Flow Margin | -64.51% | -46.46% | -251.70% | -419.71% | -184.92% | - | Upgrade
|
| Free Cash Flow Per Share | -0.72 | -0.74 | -2.96 | -3.15 | -2.21 | -2.73 | Upgrade
|
| Cash Interest Paid | 6.96 | 8.81 | 7.92 | 2.91 | 1 | - | Upgrade
|
| Levered Free Cash Flow | -19.83 | -19.99 | -72.86 | -77.17 | -44.38 | -60.79 | Upgrade
|
| Unlevered Free Cash Flow | -15.49 | -15.19 | -68.57 | -75.37 | -43.88 | -60.79 | Upgrade
|
| Change in Net Working Capital | 3.81 | 5.51 | 4.08 | 9.12 | 2.94 | -5.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.